Prediabetes and the risk of atrial fibrillation and heart failure: a propensity-matched analysis in a real-world cohort

Atrial Fibrillation

Real-world use of direct oral anticoagulants in atrial fibrillation patients with moderate/severe chronic kidney disease: a propensity score matched analysis from the START registry

Clin Res Cardiol

Menichelli D, Gazzaniga G, Poli D, Palareti G, Antonucci E, Pani A, Pignatelli P, Pastori D, START2 Register Investigators

doi: 10.1007/s00392-025-02765-7

Further Publications

Frequent premature ventricular complexes and risk of atrial fibrillation, heart failure, stroke and mortality: a meta-analysis

Heart

Kiliç ME, Arayici ME, Yilancioglu RY, Turan OE, Ozcan EE, Yilmaz MB

doi: 10.1136/heartjnl-2025-326174

Atrial Fibrillation

Insomnia and the Risk of Atrial Fibrillation: A Nationwide, Real-World Cohort Study

J Am Heart Assoc

Masuda T, Ejiri K, Kaneko H, Suzuki Y, Miyoshi T, Taya S, Iwasaki K, Nakagawa K, Nishii N, Morita H, Okada A, Fujiu K, Takeda N, Morita H, Yasunaga H, Takeda N, Yuasa S

doi: 10.1161/JAHA.125.045149

Heart Failure

Type 2 diabetes and chronic kidney disease combinations in heart failure across the ejection fraction spectrum: clinical associations, medication use, and cause-specific outcomes: a contemporary, real-world analysis of the Swedish Heart Failure Registry

Eur J Heart Fail

Ferrannini G, Pol T, Ljungman C, Dahlström U, Merolla A, Lund LH

doi: 10.1093/ejhf/xuag249

Heart, Artery and Coronary Diseases

Infective endocarditis in hypertrophic cardiomyopathy: a real-world matched cohort analysis

Heart

Rosenzveig A, Platek N, Massad F, Badwan O, Agrawal A, Menon V

doi: 10.1136/heartjnl-2026-327787

Atrial FibrillationHeart Failure

Plasma Biomarkers Associated With Heart Failure Hospitalization Among Patients With Atrial Fibrillation and Subtypes of Heart Failure

J Am Heart Assoc

Pol T, Lindbäck J, Oldgren J, Alexander JH, Siegbahn A, Wallentin L, Hijazi Z

doi: 10.1161/JAHA.125.045970

Atrial Fibrillation

Atrial fibrillation recurrence and outcomes in patients with hypertrophic cardiomyopathy: Insights from a nationwide real-world cohort

Heart Rhythm

Aglan A, Fath AR, Silver JS, Harnish P, Hook B, Maron MS, Rowin EJ

doi: 10.1016/j.hrthm.2026.03.1906

Atrial FibrillationHeart Failure

Catheter ablation of atrial fibrillation in patients with heart failure: a trial-level meta-analysis

Eur J Heart Fail

Iaconelli A, Busti M, Sensini L, Dolce P, Paglianiti DA, Scacciavillani R, Montone RA, Lunardi M, Pugliese NR, D'Amario D, Laborante R, Ruggio A, Pecorini G, Galli M, Pellicori P, Petrie M, Lambiase PD, Crijns HJGM, Crea F, Cleland JGF

doi: 10.1093/ejhf/xuag232

Atrial Fibrillation

Incident atrial fibrillation and pyoderma gangrenosum: long-term thromboembolic, heart failure, and mortality risk

Clin Res Cardiol

Kerniss H, Curman P, Olbrich H, Ständer S, Kridin K, Rottner L, Wakili R, Leistner DM, Ludwig RJ

doi: 10.1007/s00392-026-02996-2

Related content

Real-world use of direct oral anticoagulants in atrial fibrillation patients with moderate/severe chronic kidney disease: a propensity score matched analysis from the START registry

Frequent premature ventricular complexes and risk of atrial fibrillation, heart failure, stroke and mortality: a meta-analysis

Insomnia and the Risk of Atrial Fibrillation: A Nationwide, Real-World Cohort Study

Type 2 diabetes and chronic kidney disease combinations in heart failure across the ejection fraction spectrum: clinical associations, medication use, and cause-specific outcomes: a contemporary, real-world analysis of the Swedish Heart Failure Registry

Infective endocarditis in hypertrophic cardiomyopathy: a real-world matched cohort analysis

Plasma Biomarkers Associated With Heart Failure Hospitalization Among Patients With Atrial Fibrillation and Subtypes of Heart Failure

Atrial fibrillation recurrence and outcomes in patients with hypertrophic cardiomyopathy: Insights from a nationwide real-world cohort

Catheter ablation of atrial fibrillation in patients with heart failure: a trial-level meta-analysis

Incident atrial fibrillation and pyoderma gangrenosum: long-term thromboembolic, heart failure, and mortality risk